期刊
PHARMACOLOGICAL REPORTS
卷 73, 期 6, 页码 1565-1581出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s43440-021-00293-5
关键词
Alzheimer's disease; Comorbidities; Depression; Diabetes mellitus; Down syndrome; Hypercholesterolemia
资金
- National Science Centre, Poland [2015/19/B/NZ7/02847]
Alzheimer's disease is a progressive neurodegenerative disorder that mainly affects elderly individuals, and is often associated with conditions like hypercholesterolemia and hypertension. It could lead to comorbidities such as psychosis and depression. A better understanding of these comorbidities and effective use of medications may help control disease progression.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the central nervous system (CNS) leading to mental deterioration and devastation, and eventually a fatal outcome. AD affects mostly the elderly. AD is frequently accompanied by hypercholesterolemia, hypertension, atherosclerosis, and diabetes mellitus, and these are significant risk factors of AD. Other conditions triggered by the progression of AD include psychosis, sleep disorders, epilepsy, and depression. One important comorbidity is Down's syndrome, which directly contributes to the severity and rapid progression of AD. The development of new therapeutic strategies for AD includes the repurposing of drugs currently used for the treatment of comorbidities. A better understanding of the influence of comorbidities on the pathogenesis of AD, and the medications used in its treatment, might allow better control of disease progression, and more effective pharmacotherapy. [GRAPHICS] .
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据